-
UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Recommendation of "Buy" from Analysts
Источник: Buzz FX / 16 мар 2025 01:16:17 America/Chicago
UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat March 16, 2025 Share Link copied to clipboard. Remove Ads UroGen Pharma Ltd. ( NASDAQ:URGN - Get Free Report ) has received a cons
Read more...